Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Expert Opinion on Biological Therapy|May 3, 2019
Moxetumomab pasudotox for the treatment of hairy cell leukemiaAgnieszka Janus, Tadeusz RobakCellular & Molecular Biology Letters|October 12, 2005
The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapyAgnieszka Janus, Tadeusz Robak, Piotr SmolewskiAdvances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|July 1, 2014
The role of chemokines in hypertensionHelena Martynowicz, Agnieszka Janus, Dorian Nowacki, et al.Transfusion|July 8, 2016
Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patientKrzysztof Chojnowski, Agnieszka Janus, Katarzyna Bliźniewska, et al.Anti-Cancer Drugs|July 9, 2009
Rapamycin, the mTOR kinase inhibitor, sensitizes acute myeloid leukemia cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabineAgnieszka Janus, Anna Linke, Barbara Cebula, et al.Cancers|September 14, 2024
Rare Clinical Symptoms in Hairy Cell Leukemia: An OverviewTadeusz Robak, Marcin Braun, Agnieszka Janus, et al.Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 4, 2016
Resistant HypertensionAdrian Doroszko, Agnieszka Janus, Ewa Szahidewicz-Krupska, et al.Journal of Clinical Medicine|July 2, 2021
Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab PasudotoxTadeusz Robak, Agnieszka Janus, Krzysztof Jamroziak, et al.Therapeutic Drug Monitoring|October 14, 2006
No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cellsKrzysztof Jamroziak, Ewa Balcerczak, Barbara Cebula, et al.Leukemia & Lymphoma|March 25, 2025
Burkitt lymphoma in patients with chronic lymphocytic leukemia and other indolent B-cell lymphoid malignanciesTadeusz Robak, Agnieszka Pluta, Pawel Robak, et al.Pageof 3